Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Male dogs more likely to develop contagious oro-nasal cancer
"We think it's important to consider CTVT as a possible diagnosis for oro-nasal tumours in dogs" - Dr Andrea Strakova.
Researchers believe this may be due to behavioural differences.

Male dogs are four to five times more likely to develop a contagious cancer on their nose and mouth than female dogs, a study from the University of Cambridge has found.

Canine Transmissible Venereal Tumour (CTVT) is spread when dogs come into contact. An infectious cancer, the living cancer cells are able to transplant from one dog into another.

CTVT affects the genitalia of dogs most commonly, and is often transmitted during mating, however, the cancer can also affect a dog's nose, mouth and skin. The oro-nasal form of CTVT is transmitted through the sniffing or licking dogs' genitalia.

Dr Andrea Strakova, first author of the paper, explained: “We found that a very significant proportion of the nose or mouth tumours of canine transmissible cancer were in male dogs.

“We think this is because male dogs may have a preference for sniffing or licking the female genitalia, compared to vice versa. 

“The female genital tumours may also be more accessible for sniffing and licking, compared to the male genital tumours.”

In the study, researchers reviewed a database of almost 2,000 CTVT cases worldwide, finding that only 32 cases affected the nose and mouth. Of these cases, 27 were male dogs.

Dr Strakova discussed the importance of veterinary surgeons being aware of oro-nasal CTVT:
“Although canine transmissible cancer can be diagnosed and treated fairly easily, veterinarians in the UK may not be familiar with the signs of the disease because it is very rare here.

“We think it’s important to consider CTVT as a possible diagnosis for oro-nasal tumours in dogs. Treatment is very effective, using single agent Vincristine chemotherapy, and the vast majority of dogs recover.”

Signs of the oro-nasal form of CTVT include sneezing, snoring, difficulty breathing, nasal deformation or bloody or other discharge from the nose or mouth.

Published in Veterinary Record, 'Sex disparity in oronasal presentations of canine transmissible venereal tumour' is available to read here

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.